Pharmaceuticals
-
TRACON Prescribed drugs Pronounces Dosing of thirty sixth Affected person in
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) — TRACON Prescribed drugs, Inc. (Nasdaq: TCON), a medical stage biopharmaceutical firm using a cost-efficient, CRO-independent product growth platform to advance its pipeline of novel focused…
-
Centessa Prescribed drugs Pronounces Addition of Harris L.
BOSTON and LONDON, July 25, 2022 (GLOBE NEWSWIRE) — Centessa Prescribed drugs plc (Nasdaq: CNTA), a clinical-stage pharmaceutical firm with a Analysis & Improvement (R&D) innovation engine that goals to find, develop and…
-
ERS Genomics and Lepton Prescribed drugs LTD Enter CRISPR/Cas9 License Settlement
Lepton Pharmaceutical LTD is a biotechnology firm growing a proprietary, breakthrough know-how (Castling Know-how) to considerably enhance adaptive cell-mediated immune response (T-cells, CAR-T-cells, NK-cells.) Dr. Daniel Zurr, CEO of Lepton stated: “We’re very…
-
Supernus Prescription drugs to Announce Second Quarter 2022
ROCKVILLE, Md., July 25, 2022 (GLOBE NEWSWIRE) — Supernus Prescription drugs, Inc. (Nasdaq: SUPN), a biopharmaceutical firm targeted on creating and commercializing merchandise for the therapy of central nervous system (CNS) illnesses, right…
-
Mylan Prescription drugs remembers insulin glargine injection pens for potential lacking labels
ADD TOPIC TO EMAIL ALERTS Obtain an electronic mail when new articles are posted on Please present your electronic mail handle to obtain an electronic mail when…
